138 related articles for article (PubMed ID: 28389439)
1. Haematological cancers: improving outcomes. A summary of updated NICE service guidance in relation to Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS).
Cuthbert RJG
J Clin Pathol; 2017 Jun; 70(6):469. PubMed ID: 28389439
[No Abstract] [Full Text] [Related]
2. Implementation of the updated NICE haematological cancers (NG47) improving outcomes guidelines across Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS) in England: a UK NEQAS LI survey.
Cartwright A; Snowden JA; Whitehouse H; Scott S; Whitby L
J Clin Pathol; 2023 Sep; 76(9):618-623. PubMed ID: 35508367
[TBL] [Abstract][Full Text] [Related]
3. Haematological cancers: improving outcomes. A summary of updated NICE service guidance in relation to Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS).
Snowden JA; O'Connell S; Hawkins J; Dalley C; Jack A; Mannari D; McNamara C; Scott M; Shenton G; Soilleux E; Macbeth F;
J Clin Pathol; 2017 Jun; 70(6):461-468. PubMed ID: 28389440
[TBL] [Abstract][Full Text] [Related]
4. Specialist integrated haematological malignancy diagnostic services: an Activity Based Cost (ABC) analysis of a networked laboratory service model.
Dalley C; Basarir H; Wright JG; Fernando M; Pearson D; Ward SE; Thokula P; Krishnankutty A; Wilson G; Dalton A; Talley P; Barnett D; Hughes D; Porter NR; Reilly JT; Snowden JA
J Clin Pathol; 2015 Apr; 68(4):292-300. PubMed ID: 25631214
[TBL] [Abstract][Full Text] [Related]
5. Haematological malignancies: the rationale for integrated haematopathology services, key elements of organization and wider contribution to patient care.
Ireland R
Histopathology; 2011 Jan; 58(1):145-54. PubMed ID: 21261689
[TBL] [Abstract][Full Text] [Related]
6. Organisation of neoplastic haematopathology services: a UK perspective.
Jack A
Pathology; 2005 Dec; 37(6):479-92. PubMed ID: 16373228
[TBL] [Abstract][Full Text] [Related]
7. Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-analysis of published data.
Howell DA; Shellens R; Roman E; Garry AC; Patmore R; Howard MR
Palliat Med; 2011 Sep; 25(6):630-41. PubMed ID: 21228094
[TBL] [Abstract][Full Text] [Related]
8. Bony presentations of childhood haematological malignancy to the emergency room.
Teo WY; Chan MY; Ng KC; Tan AM
J Paediatr Child Health; 2012 Apr; 48(4):311-6. PubMed ID: 22077629
[TBL] [Abstract][Full Text] [Related]
9. Haematological cancers in pregnancy.
Brenner B; Avivi I; Lishner M
Lancet; 2012 Feb; 379(9815):580-7. PubMed ID: 22325663
[TBL] [Abstract][Full Text] [Related]
10. The development of haematopathology laboratories: a possible model for other pathology services.
Jack AS; Morgan GJ
J Pathol; 1998 Mar; 184(3):231-3. PubMed ID: 9614372
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of muscle function and the effect of cachexia in patients with haematological malignancy.
Fukushima T; Nakano J; Ishii S; Natsuzako A; Hirase T; Sakamoto J; Okita M
Eur J Cancer Care (Engl); 2019 Mar; 28(2):e12956. PubMed ID: 30357948
[TBL] [Abstract][Full Text] [Related]
12. The development of integrated haematopathology laboratories: a new approach to the diagnosis of leukaemia and lymphoma.
Richards SJ; Jack AS
Clin Lab Haematol; 2003 Dec; 25(6):337-42. PubMed ID: 14641135
[TBL] [Abstract][Full Text] [Related]
13. Kidney diseases associated with haematological cancers.
Ganguli A; Sawinski D; Berns JS
Nat Rev Nephrol; 2015 Aug; 11(8):478-90. PubMed ID: 26035773
[TBL] [Abstract][Full Text] [Related]
14. Haematological malignancy in the intensive care unit: microbiology results and mortality.
van Beers EJ; Müller MC; Vlaar AP; Spanjaard L; van den Bergh WM;
Eur J Haematol; 2016 Sep; 97(3):271-7. PubMed ID: 26676382
[TBL] [Abstract][Full Text] [Related]
15. Provision of survivorship care for patients with haematological malignancy at completion of treatment: A cancer nursing practice survey study.
Wallace A; Downs E; Gates P; Thomas A; Yates P; Chan RJ
Eur J Oncol Nurs; 2015 Oct; 19(5):516-22. PubMed ID: 25795159
[TBL] [Abstract][Full Text] [Related]
16. Testicular function and fertility preservation after treatment for haematological cancer.
Jahnukainen K; Mitchell RT; Stukenborg JB
Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):217-23. PubMed ID: 25871959
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of patients with haematological malignancies and their families in regional, rural and remote Queensland: the GPs' perspective.
McGrath P
Support Care Cancer; 2001 May; 9(3):199-204. PubMed ID: 11401104
[TBL] [Abstract][Full Text] [Related]
18. Improving the emergency department management of post-chemotherapy sepsis in haematological malignancy patients.
Ko HF; Tsui SS; Tse JW; Kwong WY; Chan OY; Wong GC
Hong Kong Med J; 2015 Feb; 21(1):10-5. PubMed ID: 25306894
[TBL] [Abstract][Full Text] [Related]
19. Assessing the implications of implementing the NICE guideline 95 for evaluation of stable chest pain of recent onset: a single centre experience.
Athauda-Arachchi PM; Hutcheon SD
Scott Med J; 2013 Feb; 58(1):12-5. PubMed ID: 23596021
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
